These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7731105)

  • 1. [Relative hypoparathyroidism associated with CAPD treatment using normo-calcemic (3.5mEq/1) dialysate: an approach from transperitoneal calcium balance].
    Shigematsu T; Hasegawa T; Utsunomiya M; Kubo H; Kato N; Hayakawa H; Yamamoto H; Nakayama M; Ogawa A; Kawaguchi Y
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):172-8. PubMed ID: 7731105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
    Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
    Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
    Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
    Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
    Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E; Kala AR; Grönhagen-Riska C; Ikäheimo R
    Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J; Saracho R; González O; Moina I; Martínez I
    Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type III procollagen N-peptide and hyaluronate in serum and dialysate of CAPD patients].
    Wakabayashi Y; Yamada K; Miura Y; Nakano H; Nishimura M; Tsuchida H; Shigematsu T; Kawaguchi Y; Sakai O
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):408-13. PubMed ID: 9198363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
    Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
    Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/L calcium dialysate.
    Banalagay EE; Bernardini J; Piraino B
    Adv Perit Dial; 1993; 9():271-3. PubMed ID: 8105941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium balance and intact PTH variations during haemodiafiltration.
    Argilés A; Mion CM
    Nephrol Dial Transplant; 1995 Nov; 10(11):2083-9. PubMed ID: 8643172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium mass transfer in CAPD: the role of convective transport.
    Montenegro J; Saracho R; Aguirre R; Martinez I
    Nephrol Dial Transplant; 1993; 8(11):1234-6. PubMed ID: 8302462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of long-term bone metabolism in patients with relative hypoparathyroidism after changing the calcium concentration of the dialyzate to 3mEq/L].
    Almirall J; Ponz E; López T; Trallero R; Valls R; Rodríguez A; Martínez JC; García M
    Nefrologia; 2001; 21(5):485-92. PubMed ID: 11795018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of low calcium dialysate (1.25 mmol/l; LCD) on bone metabolism in CAPD patients].
    Terawaki H; Kasai K; Kawaguchi Y; Kobayashi H; Hirano K; Ohtsuka Y; Hosoya T
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):252-7. PubMed ID: 9654908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients.
    Pagliari B; Baretta A; De Cristofaro V; Samà F; Cantaluppi A; Martis L; Imbasciati E
    Perit Dial Int; 1991; 11(4):326-9. PubMed ID: 1751598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.